Literature DB >> 27342846

Cooperative Activity of GABP with PU.1 or C/EBPε Regulates Lamin B Receptor Gene Expression, Implicating Their Roles in Granulocyte Nuclear Maturation.

Krishnakumar Malu1, Rahul Garhwal1, Margery G H Pelletier1, Deepali Gotur1, Stephanie Halene2, Monika Zwerger3, Zhong-Fa Yang4, Alan G Rosmarin4, Peter Gaines5.   

Abstract

Nuclear segmentation is a hallmark feature of mammalian neutrophil differentiation, but the mechanisms that control this process are poorly understood. Gene expression in maturing neutrophils requires combinatorial actions of lineage-restricted and more widely expressed transcriptional regulators. Examples include interactions of the widely expressed ETS transcription factor, GA-binding protein (GABP), with the relatively lineage-restricted E-twenty-six (ETS) factor, PU.1, and with CCAAT enhancer binding proteins, C/EBPα and C/EBPε. Whether such cooperative interactions between these transcription factors also regulate the expression of genes encoding proteins that control nuclear segmentation is unclear. We investigated the roles of ETS and C/EBP family transcription factors in regulating the gene encoding the lamin B receptor (LBR), an inner nuclear membrane protein whose expression is required for neutrophil nuclear segmentation. Although C/EBPε was previously shown to bind the Lbr promoter, surprisingly, we found that neutrophils derived from Cebpe null mice exhibited normal Lbr gene and protein expression. Instead, GABP provided transcriptional activation through the Lbr promoter in the absence of C/EBPε, and activities supported by GABP were greatly enhanced by either C/EBPε or PU.1. Both GABP and PU.1 bound Ets sites in the Lbr promoter in vitro, and in vivo within both early myeloid progenitors and differentiating neutrophils. These findings demonstrate that GABP, PU.1, and C/EBPε cooperate to control transcription of the gene encoding LBR, a nuclear envelope protein that is required for the characteristic lobulated morphology of mature neutrophils.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27342846      PMCID: PMC5022553          DOI: 10.4049/jimmunol.1402285

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  A lamin B receptor in the nuclear envelope.

Authors:  H J Worman; J Yuan; G Blobel; S D Georgatos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter.

Authors:  I Nuchprayoon; C P Simkevich; M Luo; A D Friedman; A G Rosmarin
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

3.  Myeloid development is selectively disrupted in PU.1 null mice.

Authors:  K L Anderson; K A Smith; K Conners; S R McKercher; R A Maki; B E Torbett
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

4.  Domain-specific interactions of human HP1-type chromodomain proteins and inner nuclear membrane protein LBR.

Authors:  Q Ye; I Callebaut; A Pezhman; J C Courvalin; H J Worman
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

5.  Identification of a novel retinoic acid-responsive element within the lamin A/C promoter.

Authors:  K Okumura; K Nakamachi; Y Hosoe; N Nakajima
Journal:  Biochem Biophys Res Commun       Date:  2000-03-05       Impact factor: 3.575

6.  GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2.

Authors:  Zhong-Fa Yang; Haojian Zhang; Leyuan Ma; Cong Peng; Yaoyu Chen; Junling Wang; Michael R Green; Shaoguang Li; Alan G Rosmarin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

7.  Mutations at the mouse ichthyosis locus are within the lamin B receptor gene: a single gene model for human Pelger-Huët anomaly.

Authors:  Leonard D Shultz; Bonnie L Lyons; Lisa M Burzenski; Bruce Gott; Rebecca Samuels; Peter A Schweitzer; Christine Dreger; Harald Herrmann; Vera Kalscheuer; Ada L Olins; Donald E Olins; Karl Sperling; Katrin Hoffmann
Journal:  Hum Mol Genet       Date:  2003-01-01       Impact factor: 6.150

8.  Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.

Authors:  Robert D Goldman; Dale K Shumaker; Michael R Erdos; Maria Eriksson; Anne E Goldman; Leslie B Gordon; Yosef Gruenbaum; Satya Khuon; Melissa Mendez; Renée Varga; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

9.  The LINC-less granulocyte nucleus.

Authors:  Ada L Olins; Thanh V Hoang; Monika Zwerger; Harald Herrmann; Hanswalter Zentgraf; Angelika A Noegel; Iakowos Karakesisoglou; Didier Hodzic; Donald E Olins
Journal:  Eur J Cell Biol       Date:  2008-11-18       Impact factor: 4.492

Review 10.  PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis.

Authors:  Pallavi Gupta; Gangenahalli U Gurudutta; Daman Saluja; Rajendra P Tripathi
Journal:  J Cell Mol Med       Date:  2009-04-06       Impact factor: 5.310

View more
  3 in total

Review 1.  The Neutrophil Nucleus: An Important Influence on Neutrophil Migration and Function.

Authors:  Harriet R Manley; Maria Cristina Keightley; Graham J Lieschke
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

2.  Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis.

Authors:  Chenghui Yang; Zhen Wang; Lili Li; Zhigang Zhang; Xiaoyan Jin; Pin Wu; Shanshan Sun; Jun Pan; Ke Su; Fang Jia; Leyi Zhang; Haijun Wang; Xiuyan Yu; Xuan Shao; Ke Wang; Fuming Qiu; Jun Yan; Jian Huang
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

3.  In-silico analysis of myeloid cells across the animal kingdom reveals neutrophil evolution by colony-stimulating factors.

Authors:  Damilola Pinheiro; Marie-Anne Mawhin; Maria Prendecki; Kevin J Woollard
Journal:  Elife       Date:  2020-11-25       Impact factor: 8.713

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.